Tirofiban Induced Thrombocytopenia: A Rare but Severe Adverse Effect
نویسندگان
چکیده
منابع مشابه
Azithromycin-induced severe Thrombocytopenia: A rare entity
Drug-induced thrombocytopenia (DITP) is a well-established but underdiagnosed condition. The condition is mostly asymptomatic, but can also cause severe bleeding [1]. Thrombocytopenia is a wellknown side effect of treatment with several types of medications. Therapeutic agents, speci ically those used for chemotherapy and immunosuppressants, tend to repress hematopoiesis and generate pancytopen...
متن کاملBevacizumab-Induced Reversible Thrombocytopenia in a Patient with Adenocarcinoma of Colon: Rare Adverse Effect of Bevacizumab
We report a case of bevacizumab- (BEV-) induced thrombocytopenia in a 59-year-old man with adenocarcinoma of colon. After colectomy, the patient was treated with twelve cycles of FOLFOX-4 (folinic acid, 5-fluorouracil, and oxaliplatin) regimen. On relapse, he was treated with FOLFIRI (folinic acid, 5-fluorouracil, and irinotecan) regimen along with BEV 10 mg/kg for 6 cycles. After that, BEV was...
متن کاملBicalutamide-induced hepatotoxicity: A rare adverse effect
PATIENT Male, 81 FINAL DIAGNOSIS: Prostate cancer Symptoms: Anorexia • dark urine • joundice • letargy MEDICATION Casodex Clinical Procedure: - Specialty: Oncology. OBJECTIVE Adverse events of drug therapy. BACKGROUND Bicalutamide is a nonsteroidal anti-androgen used extensively during the initiation of androgen deprivation therapy with a luteinizing hormone-releasing hormone (LHRH) agoni...
متن کاملCyclophosphamide-induced symptomatic hyponatremia, a rare but severe side effect: a case report
Cyclophosphamide is commonly used in the treatment of malignant diseases. Symptomatic severe hyponatremia induced by low-dose cyclophosphamide is very uncommon worldwide. We report a case of severe symptomatic hyponatremia that developed in a female breast cancer patient following the first cycle of chemotherapy containing low-dose cyclophosphamide. Her laboratory test showed serum Na of 112 mm...
متن کاملArgatroban caused severe hypercholesterolaemia in a chronic haemodialysis patient with heparin-induced thrombocytopenia: an unreported adverse effect?
Sir, Argatroban is a synthetic direct thrombin inhibitor that is used as an anticoagulant for haemodialysis (HD) in patients with type II heparin-induced thrombocytopenia (HIT) or with antithrombin III deficiency [1,2]. Although there has been no report of hypercholesterolaemia as an adverse effect of argatroban, I recently experienced a case in which severe hypercholesterolaemia was strongly s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Community Hospital Internal Medicine Perspectives
سال: 2020
ISSN: 2000-9666
DOI: 10.1080/20009666.2020.1747783